Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The American Journal of Surgical Pathology
|
September 5, 2008
Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma
David Meyronet, Patrick Massoma, Françoise Thivolet, et al.
Investigational New Drugs
|
May 28, 2016
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors
Noura Benslama, Julien Bollard, Cécile Vercherat, et al.
Oncotarget
|
April 21, 2017
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines
Patricia Freis, Julien Bollard, Justine Lebeau, et al.
Molecular and Cellular Endocrinology
|
September 17, 2014
Mechanisms of local invasion in enteroendocrine tumors: identification of novel candidate cytoskeleton-associated proteins in an experimental mouse model by a proteomic approach and validation in human tumors
Christophe Couderc, Julien Bollard, Yohann Couté, et al.
Oncotarget
|
October 9, 2015
The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors
Julien Bollard, Patrick Massoma, Cécile Vercherat, et al.
Molecular Cancer Therapeutics
|
October 21, 2017
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic <i>In Vitro</i> and <i>In Vivo</i> Antitumor Effects in Insulinoma Cells
Julien Bollard, Céline Patte, Patrick Massoma, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 16, 2015
The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study
David Meyronet, Aline Dorey, Patrick Massoma, et al.
The Journal of Pathology
|
July 2, 2019
Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors
Julien Bollard, Céline Patte, Kristina Radkova, et al.
Cancer Research
|
July 1, 2015
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
Aubin Moutal, Jérôme Honnorat, Patrick Massoma, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The American Journal of Surgical Pathology
|
September 5, 2008
Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma
David Meyronet, Patrick Massoma, Françoise Thivolet, et al.
Investigational New Drugs
|
May 28, 2016
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors
Noura Benslama, Julien Bollard, Cécile Vercherat, et al.
Oncotarget
|
April 21, 2017
mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines
Patricia Freis, Julien Bollard, Justine Lebeau, et al.
Molecular and Cellular Endocrinology
|
September 17, 2014
Mechanisms of local invasion in enteroendocrine tumors: identification of novel candidate cytoskeleton-associated proteins in an experimental mouse model by a proteomic approach and validation in human tumors
Christophe Couderc, Julien Bollard, Yohann Couté, et al.
Oncotarget
|
October 9, 2015
The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors
Julien Bollard, Patrick Massoma, Cécile Vercherat, et al.
Molecular Cancer Therapeutics
|
October 21, 2017
Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic <i>In Vitro</i> and <i>In Vivo</i> Antitumor Effects in Insulinoma Cells
Julien Bollard, Céline Patte, Patrick Massoma, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 16, 2015
The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study
David Meyronet, Aline Dorey, Patrick Massoma, et al.
The Journal of Pathology
|
July 2, 2019
Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors
Julien Bollard, Céline Patte, Kristina Radkova, et al.
Cancer Research
|
July 1, 2015
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling
Aubin Moutal, Jérôme Honnorat, Patrick Massoma, et al.
Page
of 1